Document Classification

Section Type: RESULTS

Text: These benefits persisted at 30 days (1056 [13. 6 %] vs 921 [11. 8 %] patients ; HR, 0. 87 ; 95 % CI, 0. 79-0. 95 ; P =. 001) with significant reductions in 30-day mortality (877 [11. 3 %] vs 766 [9. 8 %] ; HR, 0. 87 ; 95 % CI, 0. 79-0. 96 ; P =. 005) and reinfarction (199 [2. 6 %] vs 154 [2. 0 %] ; HR, 0. 77 ; 95 % CI, 0. 62-0. 95 ; P =. 01), and no significant differences in strokes (64 [0. 8 %] vs 80 [1. 0 %] ; P =. 19).